02:33 PM EDT, 10/01/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) plans to build a $2 billion biologics manufacturing facility in Wilson, North Carolina.

The facility will produce biologic medicines in areas including oncology, immunology, and neuroscience, Johnson & Johnson ( JNJ ) said Tuesday in a statement.

Construction work is set to begin in H1 2025, and the site is expected to employ 420 people once fully operational, the company said.

Price: 161.50, Change: -0.56, Percent Change: -0.35